These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 34964852)

  • 21. Clostridioides difficile Infection and Risk of Acute Graft-versus-Host Disease among Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
    Jabr R; El Atrouni W; Shune L; Telfah M; Gao G; He J; Abhyankar S; McGuirk J; Clough L
    Transplant Cell Ther; 2021 Feb; 27(2):176.e1-176.e8. PubMed ID: 33830032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence, Risk Factors, and Outcomes of Clostridium difficile Infections in Kidney Transplant Recipients.
    Li GJ; Trac J; Husain S; Famure O; Li Y; Kim SJ
    Transplantation; 2018 Sep; 102(9):1576-1581. PubMed ID: 29620613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency and risks associated with Clostridium difficile-associated diarrhea after pediatric solid organ transplantation: a single-center retrospective review.
    Ciricillo J; Haslam D; Blum S; Kim MO; Liu C; Paulsen G; Courter J; Danziger-Isakov L
    Transpl Infect Dis; 2016 Oct; 18(5):706-713. PubMed ID: 27492796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of Clostridioides (formerly Clostridium) difficile infection (CDI) in solid organ transplant recipients: Guidelines from the American Society of Transplantation Community of Practice.
    Mullane KM; Dubberke ER;
    Clin Transplant; 2019 Sep; 33(9):e13564. PubMed ID: 31002420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of Bezlotoxumab for Prevention of Recurrent
    Johnson TM; Howard AH; Miller MA; Allen LL; Huang M; Molina KC; Bajrovic V
    Open Forum Infect Dis; 2021 Jul; 8(7):ofab294. PubMed ID: 34262988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The outcomes of Clostridioides difficile infection in inpatient liver transplant population.
    Amjad W; Qureshi W; Malik A; Singh R; Jafri SM
    Transpl Infect Dis; 2022 Feb; 24(1):e13750. PubMed ID: 34695277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of Clostridium difficile infection in pediatric solid organ transplant recipients.
    Pant C; Deshpande A; Desai M; Jani BS; Sferra TJ; Gilroy R; Olyaee M
    Transpl Infect Dis; 2016 Feb; 18(1):31-6. PubMed ID: 26538348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fecal Microbiota Transplant in Pediatric Solid Organ Transplant Recipients.
    Rodig NM; Weatherly M; Kaplan AL; Ballal SA; Elisofon SA; Daly KP; Kahn SA
    Transplantation; 2023 Sep; 107(9):2073-2077. PubMed ID: 37211643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and outcomes of invasive fungal infection among solid organ transplant recipients: A population-based cohort study.
    Hosseini-Moghaddam SM; Ouédraogo A; Naylor KL; Bota SE; Husain S; Nash DM; Paterson JM
    Transpl Infect Dis; 2020 Apr; 22(2):e13250. PubMed ID: 31981389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology, risk factors, and outcome of Clostridium difficile infection in heart and heart-lung transplant recipients.
    Bruminhent J; Cawcutt KA; Thongprayoon C; Petterson TM; Kremers WK; Razonable RR
    Clin Transplant; 2017 Jun; 31(6):. PubMed ID: 28314071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The burden of Clostridioides difficile infection in patients with history of liver transplant and during index admission.
    Wijarnpreecha K; Aby ES; Kim D; Ungprasert P; Cheungpasitporn W; Thongprayoon C; Lukens FJ; Harnois DM; Kröner PT
    Eur J Gastroenterol Hepatol; 2021 Jun; 33(6):894-898. PubMed ID: 32541243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology, risk factors, and outcomes of Clostridium difficile infection in kidney transplant recipients.
    Neofytos D; Kobayashi K; Alonso CD; Cady-Reh J; Lepley D; Harris M; Desai N; Kraus E; Subramanian A; Treadway S; Ostrander D; Thompson C; Marr K
    Transpl Infect Dis; 2013 Apr; 15(2):134-41. PubMed ID: 23173772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clostridium difficile infection in patients with chronic kidney disease.
    Keddis MT; Khanna S; Noheria A; Baddour LM; Pardi DS; Qian Q
    Mayo Clin Proc; 2012 Nov; 87(11):1046-53. PubMed ID: 23127731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients.
    Ganetsky A; Han JH; Hughes ME; Babushok DV; Frey NV; Gill SI; Hexner EO; Loren AW; Luger SM; Mangan JK; Martin ME; Smith J; Freyer CW; Gilmar C; Schuster M; Stadtmauer EA; Porter DL
    Clin Infect Dis; 2019 May; 68(12):2003-2009. PubMed ID: 30256954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increasing Incidence of Multiply Recurrent Clostridium difficile Infection in the United States: A Cohort Study.
    Ma GK; Brensinger CM; Wu Q; Lewis JD
    Ann Intern Med; 2017 Aug; 167(3):152-158. PubMed ID: 28672282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral Vancomycin Monotherapy Versus Combination Therapy in Solid Organ Transplant Recipients With Uncomplicated Clostridium difficile Infection: A Retrospective Cohort Study.
    Korayem GB; Eljaaly K; Matthias KR; Zangeneh TT
    Transplant Proc; 2018; 50(1):137-141. PubMed ID: 29407296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intestinal Dysbiosis and Risk of Posttransplant Clostridioides difficile Infection in a Longitudinal Cohort of Liver Transplant Recipients.
    Gomez-Simmonds A; Annavajhala MK; Nunez MP; Macesic N; Park H; Uhlemann AC
    mSphere; 2022 Oct; 7(5):e0036122. PubMed ID: 36135360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiologic Trends in Clostridioides difficile Infections in a Regional Community Hospital Network.
    Turner NA; Grambow SC; Woods CW; Fowler VG; Moehring RW; Anderson DJ; Lewis SS
    JAMA Netw Open; 2019 Oct; 2(10):e1914149. PubMed ID: 31664443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential role of post-transplant hypogammaglobulinemia in the risk of Clostridium difficile infection after kidney transplantation: a case-control study.
    Origüen J; Fernández-Ruiz M; Lumbreras C; Orellana MÁ; López-Medrano F; Ruiz-Merlo T; San Juan R; García-Reyne A; González E; Polanco N; Paz-Artal E; Andrés A; Aguado JM
    Infection; 2015 Aug; 43(4):413-22. PubMed ID: 25676130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clostridium difficile infection increases mortality risk in lung transplant recipients.
    Lee JT; Kelly RF; Hertz MI; Dunitz JM; Shumway SJ
    J Heart Lung Transplant; 2013 Oct; 32(10):1020-6. PubMed ID: 23891145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.